Therma Bright Inc (TBRIF)
0.011
0.00 (0.00%)
USD |
OTCM |
Mar 28, 10:18
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 3.475M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -78.78% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 150.36 |
Price to Book Value | 2.468 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.0205 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.17% |
Profile
Therma Bright Inc is a medical diagnostic and device technology company focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company’s initial proprietary technology delivers non-invasive and pain-free skincare. The company's products include AcuVid, InterceptCS, Benepod, Venowave, TheroZap, Inretio and others.TherOZap and InterceptCS. The InterceptCS system provides controlled topical heat, without the risk of burning the skin, which will naturally prevent cold sore outbreaks. The TherOZap thermal therapy reduces the inflammatory response, relieving the symptoms of pain, itch, and inflammation associated with bites and stings. |
URL | https://www.thermabright.com |
Investor Relations URL | N/A |
HQ State/Province | Ontario |
Sector | Healthcare |
Industry | Medical Devices |
Equity Style | Small Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Therma Bright Inc is a medical diagnostic and device technology company focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company’s initial proprietary technology delivers non-invasive and pain-free skincare. The company's products include AcuVid, InterceptCS, Benepod, Venowave, TheroZap, Inretio and others.TherOZap and InterceptCS. The InterceptCS system provides controlled topical heat, without the risk of burning the skin, which will naturally prevent cold sore outbreaks. The TherOZap thermal therapy reduces the inflammatory response, relieving the symptoms of pain, itch, and inflammation associated with bites and stings. |
URL | https://www.thermabright.com |
Investor Relations URL | N/A |
HQ State/Province | Ontario |
Sector | Healthcare |
Industry | Medical Devices |
Equity Style | Small Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |